# Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

> **NCT05978622** · — · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 236 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05978622
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-30
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978622, "Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05978622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
